Amarin Corporation plc (AMRN)
NASDAQ: AMRN · Real-Time Price · USD
11.51
+0.03 (0.26%)
At close: Oct 21, 2026, 4:00 PM EDT
11.50
-0.01 (-0.09%)
After-hours: Oct 21, 2026, 7:30 PM EDT
Amarin Corporation Market Cap
Amarin Corporation has a market cap or net worth of $243.12 million as of October 21, 2026. It is the 19,590th most valuable company in the world and the 3,406th biggest in the United States. Its market cap has decreased by 41.95% in one year.
Market Cap
243.12M
Enterprise Value
-64.35M
1-Year Change
-41.95%
Global Rank
Country Rank
#3,406 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Amarin Corporation's market cap has decreased from $21.74B to $243.12M, a decrease of -98.88%. That is a compound annual growth rate of -14.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 243.12M | -16.25% |
| Dec 31, 2025 | 290.30M | 45.51% |
| Dec 31, 2024 | 199.50M | -43.83% |
| Dec 29, 2023 | 355.20M | -27.30% |
| Dec 30, 2022 | 488.60M | -63.37% |
| Dec 31, 2021 | 1.33B | -29.85% |
| Dec 31, 2020 | 1.90B | -75.29% |
| Dec 31, 2019 | 7.70B | 83.89% |
| Dec 31, 2018 | 4.18B | 285.24% |
| Dec 29, 2017 | 1.09B | 31.56% |
| Dec 30, 2016 | 825.60M | 138.20% |
| Dec 31, 2015 | 346.60M | 102.57% |
| Dec 31, 2014 | 171.10M | -49.69% |
| Dec 31, 2013 | 340.10M | -72.00% |
| Dec 31, 2012 | 1.21B | 19.39% |
| Dec 30, 2011 | 1.02B | 26.09% |
| Dec 31, 2010 | 806.80M | 1,984.75% |
| Dec 31, 2009 | 38.70M | -99.59% |
| Dec 29, 2006 | 9.44B | 90.00% |
| Dec 30, 2005 | 4.97B | -55.72% |
| Dec 31, 2004 | 11.22B | 75.97% |
| Dec 31, 2003 | 6.38B | -61.40% |
| Dec 31, 2002 | 16.53B | -77.03% |
| Dec 31, 2001 | 71.94B | 215.82% |
| Dec 29, 2000 | 22.78B | 15.79% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pfizer | 168.60B |
| Bristol-Myers Squibb Company | 122.05B |
| GSK plc | 99.56B |
| Sanofi | 96.96B |
| Biogen | 34.37B |
| Grifols | 6.82B |
| Organon & Co. | 3.61B |
| Nasus Pharma | 37.25M |